高级检索
当前位置: 首页 > 详情页

Nifedipine inhibits the activation of inflammatory and immune reactions in viral myocarditis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China [2]Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan [3]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China
出处:
ISSN:

关键词: Necrosis Matrix metalloproteinases Mast cell proteases Proinflammatory cytokines

摘要:
Aims: The aim of study is to investigate the effect of nifedipine on Viral myocarditis in an animal model. Main methods: Four-week-old male DBA/2 mice were inoculated with 2 pfu of encephalomyocarditis virus (EMCV) and randomized to nifedipine (n = 10) or control (n = 10) group. The control group was fed by regular chow and the nifedipine group contained 0.01% of nifedipine. Mast cell density was Counted, and expressions of messenger RNAs of stem cell factor (SCF), matrix metalloproteinases (MMPs), pro-collagen 1, mast cell proteases, tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) were evaluated by RT-PCR. Key findings: The area of myocardial necrosis was smaller in the nifedipine vs the control group (mean +/- SD, 1.2 +/- 1.3% vs 3.8 +/- 1.8%, respectively, P<0.005). The mast cell density (count/mm(2)) was lower in the nifedipine vs the control group (mean SD, 0.23 +/- 0.16 vs 1.08 +/- 0.45, respectively, P<0.0005). The expressions of MMPs, mast cell proteases, TNF-alpha, IL-6, SCIF and pro-collagen I were lower in the nifeclipine group than in the control group (P<0.05). Significance: Nifedipine inhibited the activation of various participants in inflammatory and immune reactions in EMCV myocarditis. (C) 2009 Elsevier Inc. All rights reserved.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2008]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验 3 区 药学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验 2 区 药学
JCR分区:
出版当年[2007]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2007版] 出版当年五年平均 出版前一年[2006版] 出版后一年[2008版]

第一作者:
第一作者机构: [1]Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China [2]Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan
通讯作者:
通讯机构: [2]Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan [*1]Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Kawahara Cho Shogoin, Kyoto 6068507, Japan
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)